Safety of late in utero exposure to zidovudine in infants born to human immunodeficiency virus-infected mothers: Bangkok. Bangkok Collaborative Perinatal HIV Transmission Study Group.

Pediatrics

Volumn 107, Issue 1, 2001, Pages

  Chotpitayasunondh, T ^a   Vanprapar, N ^a   Simonds, R J ^a   Chokephaibulkit, K ^a   Waranawat, N ^a   Mock, P ^a   Stat, M A ^a   Chuachoowong, R ^a   Young, N ^a   Mastro, T D ^a   Shaffer, N ^a  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE TRANSMISSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FOLLOW UP; GROWTH; HUMAN; INFANT; MALE; MORTALITY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; RANDOMIZED CONTROLLED TRIAL; STATISTICS; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; DISEASE TRANSMISSION, VERTICAL; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GROWTH; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRAL LOAD; ZIDOVUDINE;

EID: 0035227158     PISSN: None     EISSN: 10984275     Source Type: Journal    
DOI: None     Document Type: Article

References (0)